Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hepatitis, Chronic

Known as: Chronic hepatitis, unspecified, CHRONIC HEPATITIS, Hepatitis, Chronic [Disease/Finding] 
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2019
Review
2019
Chronic hepatitis B infection is one of the major etiological causes of liver failure, cirrhosis, and hepatocellular carcinoma… Expand
Is this relevant?
Review
2019
Review
2019
BACKGROUND & AIMS Seroclearance of hepatitis B surface antigen (HBsAg) is a marker for clearance of chronic hepatitis B virus… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy remains the gold standard for fibrosis… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Information on the stage of liver fibrosis is essential in managing chronic hepatitis C (CHC) patients. However, most models for… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Treatment with peginterferon alfa-2a alone produces significantly higher sustained virologic responses than treatment… Expand
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND A sustained virological response (SVR) rate of 41% has been achieved with interferon alfa-2b plus ribavirin therapy of… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Review
1995
Review
1995
‘Armed Forces instifute of Pathology, Washington, USA, 2University of Lisbon. Lisbon, Portugal, -‘Hofstetten, Switzerland… Expand
Is this relevant?